243 filings
8-K
MDXG
Mimedx Group Inc
27 Mar 24
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
8:24am
8-K
MDXG
Mimedx Group Inc
4 Mar 24
MIMEDX Announces Appointment of Two New Independent Directors
8:11am
8-K
MDXG
Mimedx Group Inc
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
8-K
MDXG
Mimedx Group Inc
22 Jan 24
MIMEDX Announces Improved Capital Structure with New Senior
8:09am
8-K
MDXG
Mimedx Group Inc
28 Dec 23
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
4:30pm
8-K
qvu7qy1d
13 Nov 23
MIMEDX to Participate in Upcoming Investor Conferences
8:14am
8-K
poiwhufay72xw230p
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
5l8u8h
5 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
o3q8kh7z9lrw4fwutm7
5 Sep 23
MIMEDX to Present at Upcoming Investor Conferences
8:38am
8-K
hffgv6
1 Aug 23
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
4:03pm
8-K
b484je
5 Jul 23
MIMEDX Appoints Doug Rice as Chief Financial Officer
9:02am
8-K
r626smtew cebeh
20 Jun 23
Departure of Directors or Certain Officers
4:03pm
8-K
iyy3fdt5enx9fzr
14 Jun 23
Departure of Directors or Certain Officers
4:23pm
8-K
nyf1z98vugskb 75
2 May 23
MIMEDX Announces First Quarter 2023 Operating and Financial Results
4:06pm
8-K
mqq9 4jkwt8
24 Mar 23
MIMEDX Announces Chief Financial Officer Transition
4:17pm
8-K
e8rb1ozcpddrd2y
28 Feb 23
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results
4:08pm
8-K
9c7u3a2j
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
5:27pm
8-K
btjwlfwk59xjhs3c
30 Jan 23
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
8:14am
8-K
wyyzyj
9 Jan 23
Results of Operations and Financial Condition
8:12am
8-K
xtmh18dm nn2bk
3 Jan 23
MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer
5:26pm